News
CTKB
5.52
-4.17%
-0.24
What Cytek Biosciences Holders Got Right
Simply Wall St · 1d ago
Cytek Biosciences price target raised to $7 from $6 at Stephens
TipRanks · 2d ago
Cytek Biosciences Is Maintained at Overweight by Stephens & Co.
Dow Jones · 2d ago
Cytek Biosciences Price Target Raised to $7.00/Share From $6.00 by Stephens & Co.
Dow Jones · 2d ago
Stephens & Co. Maintains Overweight on Cytek Biosciences, Raises Price Target to $7
Benzinga · 2d ago
Weekly Report: what happened at CTKB last week (1102-1106)?
Weekly Report · 3d ago
Cytek Biosciences, Inc. (NASDAQ:CTKB) Analysts Are Pretty Bullish On The Stock After Recent Results
Simply Wall St · 5d ago
Cytek Biosciences (CTKB) Q3 2026 Earnings Call Transcript
The Motley Fool · 11/05 18:29
Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (ACAD), Cytek Biosciences (CTKB) and Mineralys Therapeutics, Inc. (MLYS)
TipRanks · 11/05 14:02
Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates
NASDAQ · 11/04 23:45
Cytek Biosciences Narrows FY2026 Sales Guidance from $207.000M-$212.000M to $208.000M-$211.000M vs $209.415M Est
Benzinga · 11/04 21:14
Press Release: Cytek Biosciences Reports Third -2-
Dow Jones · 11/04 21:05
Press Release: Cytek Biosciences Reports Third -3-
Dow Jones · 11/04 21:05
Weekly Report: what happened at CTKB last week (1026-1030)?
Weekly Report · 11/02 10:19
What Cytek Biosciences Buyers Were Betting On
Simply Wall St · 10/30 13:37
Analysts Estimate Cytek Biosciences, Inc. (CTKB) to Report a Decline in Earnings: What to Look Out for
NASDAQ · 10/28 13:00
Weekly Report: what happened at CTKB last week (1019-1023)?
Weekly Report · 10/26 10:19
Cytek Biosciences price target raised to $6 from $4.75 at Stephens
TipRanks · 10/23 13:35
Weekly Report: what happened at CTKB last week (1012-1016)?
Weekly Report · 10/19 10:19
Analysts’ Top Healthcare Picks: Cytek Biosciences (CTKB), Zimmer Biomet Holdings (ZBH)
TipRanks · 10/12 13:50
More
Webull provides a variety of real-time CTKB stock news. You can receive the latest news about Cytek Biosciences, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About CTKB
Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.